【大华继显：首予精锋医疗(02675.HK)“买入”评级 目标价56港元】智通财经APP获悉，大华继显发布研报称，首次覆盖精锋医疗(02675.HK)予“买入”评级，目标价56港元。该行指出，精锋医疗成立于2017年，已迅速建立完善的腹腔镜手术机器人产品组合，在中国已完成安装22台腹腔镜手术机器人，2025年亦在海外完成安装50台。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.